NSE ScannerHospitals & Diagnostics · Hospital/Nursing Management · NSE: GPTHEALTH · data 2026-10-30
GPT Healthcare Limited
In plain words
Price: 24.2% below its 52-week high of ₹175.
Delivery: 56.3% of traded shares were kept for delivery over the last 10 sessions, against 56.1% over the last 60.
Latest results: a net profit of ₹9 cr for the quarter ended Dec 2025.
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | ₹492 cr |
| Net profit (last 12 months) | ₹47 cr |
| Sales growth, 3 years (yearly) | 25.0% |
| Profit growth, 3 years (yearly) | 26.0% |
Smart-money activity
5/100 · Weak over the last ~60 sessions, data 2026-10-30
- Delivery vs usual 0/30: Delivery 56.3% over the last 20 sessions vs 54.8% in the 40 before (1.03x); shares delivered per day 0.65x usual; 0 delivery-spike days (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
- Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
- Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Story so far
● Dividend ● Results
- 30 Jul 26Dividend Dividend ₹1.5 (ex-date) +2.0% next session
- 2 Feb 26Results Q3 FY26 results: net profit ₹9.4 cr +0.3% next session
- 14 Nov 25Dividend Dividend ₹1 (ex-date) +2.8% next session
- 29 Jul 25Dividend Dividend ₹1.5 (ex-date) +8.2% next session
- 28 Nov 24Dividend Dividend ₹1 (ex-date) +2.8% next session
From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.
Quarterly results (standalone)
| Quarter | Revenue | Net profit | Profit YoY | Op. margin | EPS ₹ |
|---|---|---|---|---|---|
| Dec 2025 | ₹120 cr | ₹9 cr | — | 17.2% | 1.14 |
Shareholding trend
| Holder | Sept 2025 | Jun 2025 |
|---|---|---|
| Promoters | 65.57% | 65.57% |
| Foreign institutions (FII) | 3.20% | 4.96% |
| Domestic institutions (DII) | 6.46% | 9.32% |
| Mutual funds | 4.64% | 4.31% |
| Retail investors | 15.68% | 14.13% |
| Number of shareholders | 67,617 | 67,060 |
Common questions
What was GPT Healthcare Limited's latest quarterly profit?
GPT Healthcare Limited reported a net profit of ₹9 cr for the quarter ended Dec 2025, on revenue of ₹120 cr.
How much do promoters hold in GPT Healthcare Limited?
Promoters held 65.57% of GPT Healthcare Limited at the end of Sept 2025, with 0.00% of promoter shares pledged.
Is GPT Healthcare Limited debt-free?
Its latest reported debt-to-equity ratio is 0.34.
What is GPT Healthcare Limited's P/E ratio?
About 23, based on the last 12 months' earnings and a price of ₹132.68 (data 2026-10-30).
What is the 52-week high and low of GPT Healthcare Limited?
The 52-week high is ₹175 and the 52-week low is ₹115.
Similar companies
Indraprastha Medical Corporation Limited (INDRAMEDCO) · KMC Speciality Hospitals (India) Limited (KMCSHIL) · Gujarat Kidney & Super Speciality Ltd. (GKSL) · Shalby Ltd. (SHALBY) · KRM Ayurveda Ltd. (KRMAYURVED)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open GPTHEALTH in NSE Scanner →